Toggle navigation
Home
Search
Services
Blog
Contact
About
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A.
Weill Medical College of Cornell University, New York, NY, United States
Search 7 grants from Michelle Lane
Search grants from Weill Medical College of Cornell University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Directing membrane function with inositol lipids in health and disease
Arenavirus Antiviral Lead Optimization
Effect of Psyllium & Oat Bran on Percent Cholesterol Absorption in Humans
Trauma & Organ Failure - Role of Lps Binding Protein
Use of Synthetic Lhrh in Children and Adults
Recently added grants:
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
Development of a Comprehensive and Dynamic AA Process Model: One Day at a Time
Mechanisms and treatments of learning deficits in Fetal Alcohol Spectrum Disorders
Cognitive Outcomes in the Pragmatic Investigation of Optimal Oxygen Targets (CO-PILOT) Trial
Academic Leadership Award at the Indiana University School of Medicine
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA075722-02
Application #
2896207
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
1999-08-10
Project End
Budget Start
1999-08-10
Budget End
2000-08-09
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Related projects
NIH 2000
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
$40,013
NIH 1999
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
NIH 1998
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
Publications
Lane, Michelle A; Xu, Juliana; Wilen, Elana W et al.
(2008)
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.
Mol Cell Endocrinol 280:63-74
Comments
Be the first to comment on Michelle Lane's grant